Ronald J. Ferguson

A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin.

P. Dayer, J. Goldstein, S. Benhamou, 1999, The Journal of pharmacology and experimental therapeutics.